Stay ahead with our PepMix Peptide Pools for emerging SARS-CoV-2 Variants

We are committed to remaining at the forefront of the ever-evolving landscape of SARS-CoV-2 research. As new variants continue to emerge, we understand the critical importance of staying well equipped. That's why we are thrilled to announce our latest offerings: New PepMix™ Peptide Pools that cover the SARS-CoV-2 virus’ spike glycoprotein and respective receptor-binding domain (RBD), that serve as invaluable tools for immune monitoring and T cell epitope identification. 

PepMix™ Peptide Pools: 

• SARS-CoV-2 (Spike HV.1)
  
• SARS-CoV-2 (Spike JN.1) – coming soon
• SARS-CoV-2 (Spike HK.3) – coming soon
• SARS-CoV-2 (Spike JG.3) – coming soon
  
  

• SARS-CoV-2 (S-RBD HV.1)
  
• SARS-CoV-2 (S-RBD JN.1) – coming soon
• SARS-CoV-2 (S-RBD HK.3 + JG.3) 
  

Our most widely used SARS-CoV-2 peptide pool covers the spike glycoprotein of the Wuhan strain and serves as the native standard when studying the virus’ immune response. Additional information on SARS2 including wild-type and variants, can be found on our website and in our references. 

Speaking of endemic infections, please explore our continuously updated catalog of PepMix Peptide Pools covering common Influenza antigens. We are dedicated to keeping you equipped during new developments. 

If you have any questions, or a tailored Custom Peptide Synthesis request please reach out to our experienced customer support team, here to provide expert guidance.